Human cytogenetic damage as a predictor of cancer risk.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 1428097)

Published in IARC Sci Publ on January 01, 1992

Authors

M Sorsa1, J Wilbourn, H Vainio

Author Affiliations

1: Institute of Occupational Health, Department of Industrial Hygiene and Toxicology, Helsinki, Finland.

Articles by these authors

Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res (1998) 2.92

Urinary thioether of employees of a chemical plant. Br J Ind Med (1978) 2.23

Childhood cancer and parental occupation in Finland. J Epidemiol Community Health (1981) 2.00

Evaluation of the carcinogenicity of chemicals: a review of the Monograph Program of the International Agency for Research on Cancer (1971 to 1977). Cancer Res (1978) 1.73

DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma. Genes Chromosomes Cancer (1998) 1.66

Spontaneous abortions among female chemical workers in Finland. Int Arch Occup Environ Health (1980) 1.65

Mutagenicity in urine of nurses handling cytostatic drugs. Lancet (1979) 1.58

Human carcinogens so far identified. Jpn J Cancer Res (1989) 1.54

Spontaneous abortions among women employed in the metal industry in Finland. Int Arch Occup Environ Health (1980) 1.53

Early diagnosis and prevention of sporadic colorectal cancer. Endoscopy (2001) 1.51

Spontaneous abortions by occupation and social class in Finland. Int J Epidemiol (1980) 1.48

Use of computerized data listings and activity profiles of genetic and related effects in the review of 195 compounds. Mutat Res (1988) 1.46

Spontaneous abortions in hospital staff engaged in sterilising instruments with chemical agents. Br Med J (Clin Res Ed) (1982) 1.44

Environmental risk factors of breast cancer. Scand J Work Environ Health (1998) 1.40

More about: cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst (2000) 1.39

Determining carcinogenicity. Science (1993) 1.39

Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health (1998) 1.38

Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis (1995) 1.38

Are evaluations of carcinogenicity by various committees worth comparing? Med Lav (1994) 1.37

Response of experimental animals to human carcinogens: an analysis based upon the IARC Monographs programme. Carcinogenesis (1986) 1.35

Transplacental carcinogens and mutagens: childhood cancer, malformations, and abortions as risk indicators. J Toxicol Environ Health (1981) 1.32

An IARC evaluation of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans as risk factors in human carcinogenesis. Environ Health Perspect (1998) 1.27

The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control (2000) 1.25

Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2001) 1.23

Spontaneous abortions in an industrialized community in Finland. Am J Public Health (1983) 1.19

Energy dependent bivalent cation translocation in rat liver mitochondria. Eur J Biochem (1970) 1.15

Asbestos exposure and the risk of lung cancer in a general urban population. Scand J Work Environ Health (1994) 1.14

From in utero and childhood exposure to parental smoking to childhood cancer: a possible link and the need for action. Hum Exp Toxicol (1999) 1.10

K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos. Int J Cancer (1993) 1.10

Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics (2001) 1.10

Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients. Int J Cancer (1991) 1.10

Wine and resveratrol: mechanisms of cancer prevention? Eur J Cancer Prev (2003) 1.09

Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.08

The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis (1993) 1.08

Pregnancy outcome of personnel in Swedish biomedical research laboratories. J Occup Environ Med (2000) 1.07

Increased sister chromatid exchange frequencies in lymphocytes of nurses handling cytostatic drugs. Scand J Work Environ Health (1980) 1.07

Immunohistochemical localization of glutathione S-transferases in human lung. Cancer Res (1993) 1.06

Comparison of alkylation rates and mutagenicity of directly acting industrial and laboratory chemicals: epoxides, glycidyl ethers, methylating and ethylating agents, halogenated hydrocarbons, hydrazine derivatives, aldehydes, thiuram and dithiocarbamate derivatives. Arch Toxicol (1980) 1.06

Allium vegetables and organosulfur compounds: do they help prevent cancer? Environ Health Perspect (2001) 1.06

Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk. Br J Cancer (2003) 1.05

Toxicity and cytogenetic studies of ultrafine titanium dioxide in cultured rat liver epithelial cells. Toxicol In Vitro (1997) 1.04

Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer (1998) 1.04

Mutagenicity in urine of workers in rubber industry. Mutat Res (1980) 1.04

Monoclonal antibody-directed characterization of cytochrome P450 isozymes responsible for toluene metabolism in rat liver. Biochem Pharmacol (1991) 1.04

Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomarkers Prev (1993) 1.03

Working group report on schistosomes, liver flukes and Helicobacter pylori. Int J Cancer (1995) 1.02

Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.00

Sex-, age- and pregnancy-induced changes in the metabolism of toluene and trichloroethylene in rat liver in relation to the regulation of cytochrome P450IIE1 and P450IIC11 content. J Pharmacol Exp Ther (1992) 1.00

Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate. Endoscopy (2004) 1.00

Trends in mesothelioma incidence and occupational mesotheliomas in Finland in 1960-1995. Scand J Work Environ Health (1997) 1.00

Genetic risks caused by occupational chemicals. Use of experimental methods and occupational risk group monitoring in the detection of environmental chemicals causing mutations, cancer and malformations. Scand J Work Environ Health (1979) 1.00

Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450. Chem Res Toxicol (1995) 0.97

Chemicals and industrial processes associated with cancer in humans. IARC Monographs, Volumes 1 to 20. IARC Monogr Eval Carcinog Risk Chem Hum Suppl (1979) 0.97

Detection of exposure to mutagenic compounds in low-tar and medium-tar cigarette smokers. Environ Res (1984) 0.96

Tissue concentrations and interaction of zinc with lead toxicity in rabbits. Toxicology (1982) 0.96

Occupational exposure to anticancer drug--potential and real hazards. Mutat Res (1985) 0.96

Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas. Carcinogenesis (1996) 0.96

A study on the mutagenic activity of styrene and styrene oxide. Scand J Work Environ Health (1976) 0.95

Detection of serum p53 protein in lung cancer patients. J Occup Med (1994) 0.95

Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol Carcinog (1999) 0.93

Barrett's oesophagus, oesophageal cancer and colon cancer: an explanation of the association and cancer chemopreventive potential of non-steroidal anti-inflammatory drugs. Eur J Cancer Prev (1998) 0.93

Serum oncoproteins and growth factors in asbestosis and silicosis patients. Int J Cancer (1992) 0.93

Effects of methylene chloride, trichloroethane, trichloroethylene, tetrachloroethylene and toluene on the development of chick embryos. Toxicology (1979) 0.92

Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst (1996) 0.92

Workgroup I: criteria for screening. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). Ann Oncol (2005) 0.92

Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis (1994) 0.92

Reproductive hazards and plastics industry. Prog Clin Biol Res (1984) 0.91

Surveillance and intervention studies on respiratory cancers in asbestos-exposed workers. Scand J Work Environ Health (1997) 0.91

Action of styrene and its metabolites sytrene oxide and styrene glycol on activities of xenobiotic biotransformation enzymes in rat liver in vivo. Toxicol Appl Pharmacol (1976) 0.91

The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis (1993) 0.90

Pulmonary toxicity of inhaled styrene in acetone-, phenobarbital- and 3-methylcholanthrene-treated rats. Arch Toxicol (1990) 0.90

Spontaneous abortions and reproductive selection mechanisms in the rubber and leather industry in Finland. Br J Ind Med (1983) 0.90

A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos. Cancer Epidemiol Biomarkers Prev (1996) 0.90

Action of mild alkali on UDPglucuronosyltransferase of hepatic microsomes. Acta Pharmacol Toxicol (Copenh) (1976) 0.90

Target organs for carcinogenicity of chemicals and industrial exposures in humans: a review of results in the IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Cancer Res (1984) 0.89

Effects of phenoxyherbicides and glyphosate on the hepatic and intestinal biotransformation activities in the rat. Acta Pharmacol Toxicol (Copenh) (1983) 0.88

Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients. Environ Health Perspect (1992) 0.88

Bacterial urinary assay in monitoring exposure to mutagens and carcinogens. IARC Sci Publ (1984) 0.88

Hypolipidemia and peroxisome proliferation induced by phenoxyacetic acid herbicides in rats. Biochem Pharmacol (1983) 0.88

Chromosome aberrations and their relevance to metal carcinogenesis. Environ Health Perspect (1981) 0.88

Exposure to 4,4'-methylenediphenyl diisocyanate (MDI) during moulding of rigid polyurethane foam: determination of airborne MDI and urinary 4,4'-methylenedianiline (MDA). Analyst (2001) 0.87

Asbestos exposure among Finnish lung cancer patients: occupational history and fiber concentration in lung tissue. Am J Ind Med (1993) 0.87

Detection of ras gene mutations in human lung cancer: comparison of two screening assays based on the polymerase chain reaction. Environ Health Perspect (1992) 0.87

Data on the carcinogenicity of chemicals in the IARC Monographs programme. Carcinogenesis (1985) 0.87

A comparative study on the contribution of cytochrome P450 isozymes to metabolism of benzene, toluene and trichloroethylene in rat liver. Biochem Pharmacol (1992) 0.87

p53 antibodies in the sera of lung cancer patients: comparison with p53 mutation in the tumour tissue. Int J Cancer (1995) 0.87

The combined toxicity of technical grade xylene and ethanol in the rat. Xenobiotica (1980) 0.86

Occupational exposures and cancers of the endometrium and cervix uteri in Finland. Am J Ind Med (2001) 0.86

Preferential binding of benzo[a]pyrene into nuclear matrix fraction. Cancer Lett (1979) 0.86

Carcinogenic properties of pharmaceutical agents evaluated in the IARC Monographs programme. Carcinogenesis (1991) 0.85

Specific binding of CS2 metabolites to microsomal proteins in rat liver. Acta Pharmacol Toxicol (Copenh) (1977) 0.85

Identification of carcinogens within the IARC monograph program. Scand J Work Environ Health (1992) 0.85

Detection of increased amounts of the extracellular domain of the c-erbB-2 oncoprotein in serum during pulmonary carcinogenesis in humans. Int J Cancer (1994) 0.85

Lobe of origin of lung cancer among asbestos-exposed patients with or without diffuse interstitial fibrosis. Scand J Work Environ Health (1993) 0.85

Identification of chemicals carcinogenic to man. Toxicol Pathol (1984) 0.84

Immunochemical characterization of cytochrome P-450 isozymes responsible for benzene oxidation in the rat liver. Carcinogenesis (1989) 0.84